Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

The latest on manufacturing and potential treatments for COVID-19 with news from Moderna, Sanofi, GSK, Abbott, Roche, Gilead, Novartis, Daiichi Sankyo, and others. Moderna in Talks to Supply Japan with 40 M Doses of COVID-19 VaccineModerna, a...

Novartis has set a target to achieve full carbon neutrality across its supply chain by 2030, in addition to its already stated target for carbon neutrality in its own operations by 2025. This new target replaces a previous target aiming for a 50%...

Nestlé Health Science (NHSc) has agreed to acquire Aimmune Therapeutics, a company developing and commercializing treatments for food allergies, for approximately $2.1 billion. The move provides Nestlé with the remaining shares of Aimmune not...

Regeneron Pharmaceuticals, a Tarrytown, New York-based biopharmaceutical company, reports that it will add more than 400 new jobs at its Industrial Operations and Product Supply (IOPS) campus in Limerick, Ireland, to bring the total headcount at...

A roundup of news from the US (AbbVie, Colorcon Ventures, BioMarin Pharmaceutical, and Bayshore Pharmaceuticals). AbbVie, Harvard Form $30-M Research Pact for Emergent Viral DiseasesAbbVie and Harvard University have entered into a $30-million...

Blackstone, a private investment firm, has agreed to acquire Takeda Consumer Healthcare Company (TCHC), a subsidiary of Takeda and a provider of over-the-counter (OTC) medicines in Japan, for a total value of JPY 242.0 billion ($2.3 billion). The...

Bristol Myers Squibb (BMS) has agreed to acquire Forbius, a Montréal-based clinical-stage biopharmaceutical company developing biotherapeutics for treating cancer and fibrotic diseases. Financial terms were not disclosed. Forbius has developed a...

A roundup of news from Denmark (Novo Nordisk), Germany (Evotec, Novo Nordisk), Japan (Takeda), and the US (Lupin, Sun Pharma, Alnylam, Teva, and others). Denmark Novo Nordisk To Invest $135 M in Danish Production FacilitiesNovo Nordisk plans to...

Sanofi has agreed to acquire Principia Biopharma, a South San Francisco, California-based clinical-stage biopharmaceutical company focused on immune-mediated diseases, for $3.68 billion. Principia Biopharma is developing Bruton’s tyrosine kinase...